3 prosjekter

KLINISK-Klinisk forskning

Nordic Melanoma Meeting in Oslo, 6-8 Sept. 2012

For tiden finner det sted en liten revolusjon i melanombehandlingen. For første gang på 30 år har vi nå medikamenter som forlenger levetid og muligens helbreder pasienter med spredning fra malignt melanom. Denne utviklingen gir helt nye muligheter for mel anomforskning. Møtet ble tidligere arrang...

Tildelt: kr 12 327

Prosjektperiode: 2012-2012

Sted: Oslo

FRIMEDBIO-Fri prosj.st. med.,helse,biol

Lung cancer - characterization of biological factors for use in diagnosis, prognostication and therapy

Lung cancer is the leading cause of cancer-related death. Treatment results depend on stage, but are overall poor, due to the fact that most patients are diagnosed with advanced disease, but also lack of understanding of involved cellular and molecular di sease mechanisms. From 2005, all lung can...

Tildelt: kr 5,6 mill.

Prosjektperiode: 2009-2014

Sted: Oslo

BIA-Brukerstyrt innovasjonsarena

Combination of chemotherapy, radiation and immunotherapy in patients with non-small cell lung cancer; improving cancer vaccine efficacy.

GemVax is in the international forefront in the development of peptide based active immunotherapy for treatment of cancer. GV1001 is a telomerase based cancer vaccine which in principle can act as a universal cancer vaccine. GV1001 is GemVax' lead com pound. The product has been developed in ...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2006-2009

Sted: Oslo